LTRN News
Archived Headlines
- Clinical stage oncology biotech Lantern Pharma sets terms for $25 million IPO 05/12/20
- US IPO Week Ahead: GAN bets on itself in a 3 IPO week 05/01/20
- US IPO Week Ahead: Another quiet week for the IPO market with 1 biotech 04/17/20
- US IPO Weekly Recap: 2 new filings keep the IPO market moving 04/17/20
- Clinical stage oncology biotech Lantern Pharma files for a $29 million IPO 04/16/20
US IPO Weekly Recap: Vroom soars in another 8 IPO week
Eight IPOs and one SPAC entered the public markets this past week led by Vroom (VRM), which popped 118% in ...read more
Lantern Pharma prices upsized IPO at $15, the low end of the range
Lantern Pharma, a biotech redeveloping abandoned drugs for non-small cell lung cancer, raised $26 million by offering 1.8 million shares at $15, the low end of the range of $15 to $17. Lantern Pharma plans to list on the Nasdaq under the symbol LTRN....read more
US IPO Week Ahead: AZEK and Vroom take the lead in another 8 IPO week
Updated Monday, 6/8. Following the busiest week yet for the 2020 IPO market, another eight IPOs and one SPAC plan to raise $2 billion in the week ahead, led by building products maker AZEK (AZEK) online auto marketplace...read more
US IPO Week Ahead: Online insurance platform plans largest US IPO since February
Updated Monday 5/18 The largest US IPO since February, a SPAC, and a medical device company IPO are on the calendar for the week ahead. SelectQuote (SLQT), an online platform for comparing and purchasing insurance, plans to raise...read more